Enhanced but variant-dependent serological and cellular immune responses to third-dose BNT162b2 vaccination in patients with multiple myeloma
Gespeichert in:
| Veröffentlicht in: | Cancer cell 2022-06, Vol.40 (6), p.587-589 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 589 |
|---|---|
| container_issue | 6 |
| container_start_page | 587 |
| container_title | Cancer cell |
| container_volume | 40 |
| creator | Enssle, Julius C. Campe, Julia Büchel, Sarah Moter, Alina See, Frederic Grießbaum, Katharina Rieger, Michael A. Wolf, Sebastian Ballo, Olivier Steffen, Björn Serve, Hubert Rabenau, Holger F. Widera, Marek Bremm, Melanie Huenecke, Sabine Ciesek, Sandra von Metzler, Ivana Ullrich, Evelyn |
| description | |
| doi_str_mv | 10.1016/j.ccell.2022.05.003 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9116569</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1535610822002148</els_id><sourcerecordid>2667785025</sourcerecordid><originalsourceid>FETCH-LOGICAL-c487t-56264f509c4ca5ca94d19fdfdb88fe64d99a0b7a8ea316923a6ae3ac9ddc8bb53</originalsourceid><addsrcrecordid>eNp9kcFu1TAQRSMEoqXwBUjISzYJdhI7zgIkWpUWqYJNWVsTe9Lnp8QOtvNQP4J_xuGVCjasPJLn3ju6pyheM1oxysS7faU1TlNV07quKK8obZ4Up0x2smyEFE_zzBteCkblSfEixj3NKtb1z4uThnMpu0acFj8v3Q6cRkOGNZEDBAsulQYXdAZdIhGDn_yd1TARcIZsiesEgdh5Xh2SgHHxLmIkyZO0s8GUxkck519umaiHOltqbR0k6x2xjix5yr6R_LBpR-Z1SnaZkMz3OPkZXhbPRpgivnp4z4pvny5vL67Lm69Xny8-3pS6lV0quahFO3La61YD19C3hvWjGc0g5YiiNX0PdOhAIjRM9HUDArAB3Ruj5TDw5qz4cPRd1mFGo_NFASa1BDtDuFcerPr3x9mduvMH1TMmuOizwdsHg-C_rxiTmm3cugGHfo2qFqLrJKf1ltUcV3XwMQYcH2MYVRtItVe_QaoNpKJcZZBZ9ebvCx81f8jlhffHBcw9HSwGFXVuNpO0AXVSxtv_BvwC3Em1PA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2667785025</pqid></control><display><type>article</type><title>Enhanced but variant-dependent serological and cellular immune responses to third-dose BNT162b2 vaccination in patients with multiple myeloma</title><source>MEDLINE</source><source>Cell Press Free Archives</source><source>Elsevier ScienceDirect Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Enssle, Julius C. ; Campe, Julia ; Büchel, Sarah ; Moter, Alina ; See, Frederic ; Grießbaum, Katharina ; Rieger, Michael A. ; Wolf, Sebastian ; Ballo, Olivier ; Steffen, Björn ; Serve, Hubert ; Rabenau, Holger F. ; Widera, Marek ; Bremm, Melanie ; Huenecke, Sabine ; Ciesek, Sandra ; von Metzler, Ivana ; Ullrich, Evelyn</creator><creatorcontrib>Enssle, Julius C. ; Campe, Julia ; Büchel, Sarah ; Moter, Alina ; See, Frederic ; Grießbaum, Katharina ; Rieger, Michael A. ; Wolf, Sebastian ; Ballo, Olivier ; Steffen, Björn ; Serve, Hubert ; Rabenau, Holger F. ; Widera, Marek ; Bremm, Melanie ; Huenecke, Sabine ; Ciesek, Sandra ; von Metzler, Ivana ; Ullrich, Evelyn</creatorcontrib><identifier>ISSN: 1535-6108</identifier><identifier>EISSN: 1878-3686</identifier><identifier>DOI: 10.1016/j.ccell.2022.05.003</identifier><identifier>PMID: 35588736</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>BNT162 Vaccine ; booster ; COVID-19 ; Delta ; Humans ; immune response ; Immunity, Cellular ; Letter ; Multiple Myeloma ; Omicron ; SARS-CoV-2 ; T cells ; Vaccination</subject><ispartof>Cancer cell, 2022-06, Vol.40 (6), p.587-589</ispartof><rights>2022 Elsevier Inc.</rights><rights>2022 Elsevier Inc. 2022 Elsevier Inc.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c487t-56264f509c4ca5ca94d19fdfdb88fe64d99a0b7a8ea316923a6ae3ac9ddc8bb53</citedby><cites>FETCH-LOGICAL-c487t-56264f509c4ca5ca94d19fdfdb88fe64d99a0b7a8ea316923a6ae3ac9ddc8bb53</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S1535610822002148$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,776,780,881,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35588736$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Enssle, Julius C.</creatorcontrib><creatorcontrib>Campe, Julia</creatorcontrib><creatorcontrib>Büchel, Sarah</creatorcontrib><creatorcontrib>Moter, Alina</creatorcontrib><creatorcontrib>See, Frederic</creatorcontrib><creatorcontrib>Grießbaum, Katharina</creatorcontrib><creatorcontrib>Rieger, Michael A.</creatorcontrib><creatorcontrib>Wolf, Sebastian</creatorcontrib><creatorcontrib>Ballo, Olivier</creatorcontrib><creatorcontrib>Steffen, Björn</creatorcontrib><creatorcontrib>Serve, Hubert</creatorcontrib><creatorcontrib>Rabenau, Holger F.</creatorcontrib><creatorcontrib>Widera, Marek</creatorcontrib><creatorcontrib>Bremm, Melanie</creatorcontrib><creatorcontrib>Huenecke, Sabine</creatorcontrib><creatorcontrib>Ciesek, Sandra</creatorcontrib><creatorcontrib>von Metzler, Ivana</creatorcontrib><creatorcontrib>Ullrich, Evelyn</creatorcontrib><title>Enhanced but variant-dependent serological and cellular immune responses to third-dose BNT162b2 vaccination in patients with multiple myeloma</title><title>Cancer cell</title><addtitle>Cancer Cell</addtitle><subject>BNT162 Vaccine</subject><subject>booster</subject><subject>COVID-19</subject><subject>Delta</subject><subject>Humans</subject><subject>immune response</subject><subject>Immunity, Cellular</subject><subject>Letter</subject><subject>Multiple Myeloma</subject><subject>Omicron</subject><subject>SARS-CoV-2</subject><subject>T cells</subject><subject>Vaccination</subject><issn>1535-6108</issn><issn>1878-3686</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kcFu1TAQRSMEoqXwBUjISzYJdhI7zgIkWpUWqYJNWVsTe9Lnp8QOtvNQP4J_xuGVCjasPJLn3ju6pyheM1oxysS7faU1TlNV07quKK8obZ4Up0x2smyEFE_zzBteCkblSfEixj3NKtb1z4uThnMpu0acFj8v3Q6cRkOGNZEDBAsulQYXdAZdIhGDn_yd1TARcIZsiesEgdh5Xh2SgHHxLmIkyZO0s8GUxkck519umaiHOltqbR0k6x2xjix5yr6R_LBpR-Z1SnaZkMz3OPkZXhbPRpgivnp4z4pvny5vL67Lm69Xny8-3pS6lV0quahFO3La61YD19C3hvWjGc0g5YiiNX0PdOhAIjRM9HUDArAB3Ruj5TDw5qz4cPRd1mFGo_NFASa1BDtDuFcerPr3x9mduvMH1TMmuOizwdsHg-C_rxiTmm3cugGHfo2qFqLrJKf1ltUcV3XwMQYcH2MYVRtItVe_QaoNpKJcZZBZ9ebvCx81f8jlhffHBcw9HSwGFXVuNpO0AXVSxtv_BvwC3Em1PA</recordid><startdate>20220613</startdate><enddate>20220613</enddate><creator>Enssle, Julius C.</creator><creator>Campe, Julia</creator><creator>Büchel, Sarah</creator><creator>Moter, Alina</creator><creator>See, Frederic</creator><creator>Grießbaum, Katharina</creator><creator>Rieger, Michael A.</creator><creator>Wolf, Sebastian</creator><creator>Ballo, Olivier</creator><creator>Steffen, Björn</creator><creator>Serve, Hubert</creator><creator>Rabenau, Holger F.</creator><creator>Widera, Marek</creator><creator>Bremm, Melanie</creator><creator>Huenecke, Sabine</creator><creator>Ciesek, Sandra</creator><creator>von Metzler, Ivana</creator><creator>Ullrich, Evelyn</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20220613</creationdate><title>Enhanced but variant-dependent serological and cellular immune responses to third-dose BNT162b2 vaccination in patients with multiple myeloma</title><author>Enssle, Julius C. ; Campe, Julia ; Büchel, Sarah ; Moter, Alina ; See, Frederic ; Grießbaum, Katharina ; Rieger, Michael A. ; Wolf, Sebastian ; Ballo, Olivier ; Steffen, Björn ; Serve, Hubert ; Rabenau, Holger F. ; Widera, Marek ; Bremm, Melanie ; Huenecke, Sabine ; Ciesek, Sandra ; von Metzler, Ivana ; Ullrich, Evelyn</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c487t-56264f509c4ca5ca94d19fdfdb88fe64d99a0b7a8ea316923a6ae3ac9ddc8bb53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>BNT162 Vaccine</topic><topic>booster</topic><topic>COVID-19</topic><topic>Delta</topic><topic>Humans</topic><topic>immune response</topic><topic>Immunity, Cellular</topic><topic>Letter</topic><topic>Multiple Myeloma</topic><topic>Omicron</topic><topic>SARS-CoV-2</topic><topic>T cells</topic><topic>Vaccination</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Enssle, Julius C.</creatorcontrib><creatorcontrib>Campe, Julia</creatorcontrib><creatorcontrib>Büchel, Sarah</creatorcontrib><creatorcontrib>Moter, Alina</creatorcontrib><creatorcontrib>See, Frederic</creatorcontrib><creatorcontrib>Grießbaum, Katharina</creatorcontrib><creatorcontrib>Rieger, Michael A.</creatorcontrib><creatorcontrib>Wolf, Sebastian</creatorcontrib><creatorcontrib>Ballo, Olivier</creatorcontrib><creatorcontrib>Steffen, Björn</creatorcontrib><creatorcontrib>Serve, Hubert</creatorcontrib><creatorcontrib>Rabenau, Holger F.</creatorcontrib><creatorcontrib>Widera, Marek</creatorcontrib><creatorcontrib>Bremm, Melanie</creatorcontrib><creatorcontrib>Huenecke, Sabine</creatorcontrib><creatorcontrib>Ciesek, Sandra</creatorcontrib><creatorcontrib>von Metzler, Ivana</creatorcontrib><creatorcontrib>Ullrich, Evelyn</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Cancer cell</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Enssle, Julius C.</au><au>Campe, Julia</au><au>Büchel, Sarah</au><au>Moter, Alina</au><au>See, Frederic</au><au>Grießbaum, Katharina</au><au>Rieger, Michael A.</au><au>Wolf, Sebastian</au><au>Ballo, Olivier</au><au>Steffen, Björn</au><au>Serve, Hubert</au><au>Rabenau, Holger F.</au><au>Widera, Marek</au><au>Bremm, Melanie</au><au>Huenecke, Sabine</au><au>Ciesek, Sandra</au><au>von Metzler, Ivana</au><au>Ullrich, Evelyn</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Enhanced but variant-dependent serological and cellular immune responses to third-dose BNT162b2 vaccination in patients with multiple myeloma</atitle><jtitle>Cancer cell</jtitle><addtitle>Cancer Cell</addtitle><date>2022-06-13</date><risdate>2022</risdate><volume>40</volume><issue>6</issue><spage>587</spage><epage>589</epage><pages>587-589</pages><issn>1535-6108</issn><eissn>1878-3686</eissn><cop>United States</cop><pub>Elsevier Inc</pub><pmid>35588736</pmid><doi>10.1016/j.ccell.2022.05.003</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1535-6108 |
| ispartof | Cancer cell, 2022-06, Vol.40 (6), p.587-589 |
| issn | 1535-6108 1878-3686 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9116569 |
| source | MEDLINE; Cell Press Free Archives; Elsevier ScienceDirect Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals |
| subjects | BNT162 Vaccine booster COVID-19 Delta Humans immune response Immunity, Cellular Letter Multiple Myeloma Omicron SARS-CoV-2 T cells Vaccination |
| title | Enhanced but variant-dependent serological and cellular immune responses to third-dose BNT162b2 vaccination in patients with multiple myeloma |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-10T02%3A35%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Enhanced%20but%20variant-dependent%20serological%20and%20cellular%20immune%20responses%20to%20third-dose%20BNT162b2%20vaccination%20in%20patients%20with%20multiple%20myeloma&rft.jtitle=Cancer%20cell&rft.au=Enssle,%20Julius%20C.&rft.date=2022-06-13&rft.volume=40&rft.issue=6&rft.spage=587&rft.epage=589&rft.pages=587-589&rft.issn=1535-6108&rft.eissn=1878-3686&rft_id=info:doi/10.1016/j.ccell.2022.05.003&rft_dat=%3Cproquest_pubme%3E2667785025%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2667785025&rft_id=info:pmid/35588736&rft_els_id=S1535610822002148&rfr_iscdi=true |